Pharmacodynamics of levofloxacin and ciprofloxacin in a murine pneumonia model: peak concentration/MIC versus area under the curve/MIC ratios

Clicks: 509
ID: 120431
2003
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #5 of 105 articles by views in Antimicrobial agents and chemotherapy

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
During the last decade some studies have shown that the area under the curve (AUC)/MIC ratio is the pharmacodynamic index that best predicts the efficacies of quinolones, while other studies suggest that the predictive value of the peak concentration/MIC (peak/MIC) ratio is superior to the AUC/MIC r …
Reference Key
f2003antimicrobialpharmacodynamics Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Scaglione F;Mouton JW;Mattina R;Fraschini F;;
Journal Antimicrobial agents and chemotherapy
Year 2003
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/12936969
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE Mice Inbred C57BL animals pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't female Survival Analysis pneumonia pneumococcal / microbiology microbial sensitivity tests anti-infective agents / therapeutic use ciprofloxacin / therapeutic use microbial dose-response relationship drug levofloxacin* area under curve ofloxacin / therapeutic use protein binding colony count anti-infective agents / pharmacokinetics* streptococcus pneumoniae / drug effects pneumococcal / drug therapy pmid:12936969 pmc182632 doi:10.1128/aac.47.9.2749-2755.2003 f scaglione j w mouton f fraschini ciprofloxacin / pharmacokinetics* ofloxacin / pharmacokinetics* pneumococcal / metabolism*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.